Cargando…
MicroRNAs and DNA-Damaging Drugs in Breast Cancer: Strength in Numbers
MicroRNAs are a class of small non-coding regulatory RNAs playing key roles in cancer. Breast cancer is the most common female malignancy worldwide and is categorized into four molecular subtypes: luminal A and B, HER2+ and triple-negative breast cancer (TNBC). Despite the development of multiple ta...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129576/ https://www.ncbi.nlm.nih.gov/pubmed/30234015 http://dx.doi.org/10.3389/fonc.2018.00352 |